CLU and non-small cell lung carcinoma: We detected no significant impact of p38 inhibitor on the growth of Hop62-shCLU (Figure S5A-B), suggesting that this branch might not play an important role in mediating growth-promoting effect in CLU knockdown NSCLC cells.